NEW YORK, April 14, 2015 /PRNewswire/ -- Breathe eCig Corp. (OTCQB: BVAP) ("Breathe" or "the Company"), the electronic cigarette industry innovator and pioneer, today announced the execution of a distribution agreement with a major New York City based distributor ("the Distributor") capable of placing Breathe's proprietary ECIG devices, as well as complimentary products, in as many as 5,000 unique stores and locations within the New York City Metropolitan area ("N.Y. Metro area").
Under the terms of the agreement, Breathe has committed sufficient capital to the Distributor to purchase dedicated vans wrapped in the corporate logo, display cases, marketing materials and T-Shirts. The Company has established a launch date of June 1, 2015 to begin sales of its products throughout the N.Y. Metro area. In addition, the Company plans to actively support its brand with an aggressive marketing plan encompassing, but not limited to: local and national media partnerships, publicity, event sponsorships and grass roots sampling programs throughout the N.Y. Metro area.
On April 2, 2015, Breathe announced a manufacturing agreement with Hong Kong-based The KMG Group ("KMG" or "the Manufacturer") for an initial product order exceeding $300,000 USD. As of today's date, KMG is already in production of over 100,000 units for Breathe and the Company anticipates that a substantial portion of this inventory will be allocated pursuant to this distribution agreement. The Company will commit to updating shareholders at the end of each month the approximate number of N.Y. Metro area stores and locations carrying its product(s), commencing June 30, 2015.
"Breathe is fortunate to have partnered with a distributor with such extensive relationships in the N.Y. Metro area," said Breathe's CEO and founder, Josh Kimmel. "Management has worked diligently to ensure the timely delivery of product, display cases and complimentary materials so that June 1, 2015 is extremely successful. We look forward to supporting our brand effectively and growing revenues in the short, intermediate and long terms."
Additionally, on March 16, 2015, Breathe eCig Corp. (OTCQB: BVAP) and Tauriga Sciences, Inc. (OTCBQ: TAUG) ("Tauriga") entered into a license agreement to co-develop and co-commercialize a new legal cannabidiol ("CBD") e-cigarette. Breathe expects that, when available, this jointly developed CBD e-cigarette will be sold in the N.Y. Metro area alongside Breathe's existing products. Breathe and Tauriga will share the net profits equally from the CBD e-cigarette product line.
To find out more about Breathe eCig Corp., visit www.breathecig.com.
About Breathe eCig Corp.
Breathe was founded in 2012 as a research and development company in Knoxville, Tennessee with the mission to develop a better e-cigarette than was available on the market. Now holding multiple patents (pending) for its groundbreaking product, BVAP, Breathe is not your typical e-cig manufacturer. With a commitment to remaining socially responsible through innovative product development, consumer outreach and education, Breathe challenges the e-cig industry establishment. To find out more, visit www.breathecig.com.
About Tauriga Sciences, Inc.:
Tauriga Sciences, Inc. (TAUG) is a diversified life sciences company focused on generating profitable revenues in the natural wellness sector and in developing a proprietary synthetic biology platform technology. The mission of the Company is to acquire and build a diversified portfolio of cutting edge technology assets that is capital efficient and of significant value to the shareholders. The Company's business model includes the acquisition of licenses, equity stakes, rights on both an exclusive and non-exclusive basis, and entire businesses. Management is firmly committed to building lasting shareholder value in the short, intermediate, and long terms. Please visit the Company's corporate website at www.tauriga.com and the Company's e-commerce website at www.taurigastore.com.
DISCLAIMER < >
This press release contains statements that are "Forward-Looking" in nature (within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended). All statements regarding the Company's financial position, potential, business strategy, plans and objectives for future operations are Forward-Looking statements. Many of these statements contain words such as "goal," "aims," "may," "expect," "believe," "intend," "anticipate," "estimate," "continue," "would," "exceed," "should," "steady," "plan," "potential," "dramatic," and variations of such words and similar expressions identify Forward-Looking statements, but their absence does not mean that a statement is not a Forward-Looking statement. Because Forward-Looking statements involve future risks and uncertainties, there are many factors that could cause actual results to differ materially from those expressed or implied. The Company cannot predict the actual effect these factors will have on its results and many of the factors and their effects are beyond the Company's control. Any forward-looking statement made by the Company speaks only as of the date on which it is made. The Company is under no obligation to, and expressly disclaims any obligation to, update or alter its forward-looking statements, whether as a result of new information, subsequent events or otherwise. Given these uncertainties, you should not rely too heavily on these forward-looking statements.
Information for the Educated Investor
For further information regarding these and other risks related to Breathe eCigs' business, investors should consult Breathe eCigs' filings with the Securities and Exchange Commission, available at www.sec.gov, and contact Company counsel at [email protected].
Mr. Joshua Kimmel
Chief Executive Officer
Tel: +1(800) 905-4014
Local: +1(865) 281-1330
SOURCE Breathe eCig Corp.